Mitochondrial unfolded protein response inhibitors targeting HSPD1 induced accumulation of poly-ubiquitinated proteins and metabolic stress, thereby suppressing AKT/mTOR signaling in prostate cancer 59. The gene discussed is AKT1; the disease is prostate carcinoma.